Targeted drug delivery involves designing nanoparticles to recognize and bind to specific molecules on cancer cells. This can be achieved using ligands, antibodies, or peptides that specifically bind to receptors on the cancer cells. Once the nanoparticles bind to the cancer cells, they release their therapeutic payload directly into the cells, enhancing the efficacy of the treatment and reducing side effects.
